Description
Cervical Fusion Market Research Report – forecast till 2030
Market Overview
The cervical Fusion Market is registering a CAGR of 4.72% during the forecast period. Cervical spinal fusion, otherwise called arthrodesis, is a surgery to associate bones in the cervical vertebral section of the spine underneath the neck. In the clinical areas, there are various techniques for performing cervical spinal fusion surgery wherein the most dominating is embedding a bone join for normal regrowth of the bone. Other than that, the utilization of fake units, for example, metal unions or polymer joins is likewise a substantial strategy utilized. These engineered embed joins are likewise used to keep the vertebrae intact until the development of another bone happens between them.
In view of our exploration, we have distinguished that the full-scale factors that are driving the worldwide market are the rising recurrence of cervical spondylosis among corporate specialists and the rising events of cervical wounds in vehicle mishaps. Further, the presentation of biomaterial cervical fusion inserts is another element driving the development of the cervical fusion market. In any case, then again, stresses over post-careful medicines are filling in as a smothering component for industry development. Coordinated efforts between enormous organizations and local players, then again, help the market’s allure.
Market Segment Overview
Based on Fusion Type the Global Cervical Fusion Market is classified into Anterior Interbody Fusion, Anterior Cervical Fusion, Posterior Fusion, and Others.
Based on the type segment the market is divided into Metal, Polymer, and Others.
The Surgery segment is bifurcated into Minimally Invasive Spine Surgery and Open Spine Surgery. The End User segment divides the market into Orthopedic Clinics, Multispecialty Hospitals, Neurology Clinics, and Others.
Regional Analysis
North America represented USD 882.93 million in 2021 and is supposed to show a 5.06% CAGR during the review time frame. This is credited to the developing rate of spine irregularities like scoliosis, kyphosis, and lordosis, as well as a maturing populace across the area.
Europe represents the second-biggest piece of the pie because of the accessibility of state-of-the-art treatment offices, government backing for the development of the medical services industry, a maturing populace, and an expansion in the occurrence of degenerative circle illness, rheumatoid joint pain, and osteoarthritis.
The Asia-Pacific Cervical Fusion Market is supposed to develop at a CAGR of 19.97% from 2022 to 2030. This is because of expanded paces of osteoarthritis and degenerative plate illness, the quickly developing clinical travel industry, and rising medical care costs
For example, India is inclined toward objective for clinical voyagers because of the accessibility of specialists, state-of-the-art innovation, and practical medicines.
Major Players
The key companies operating in the Cervical Fusion market are Medtronic Inc (Ireland), Abbott Laboratories (US), Stryker Corporation (US), DePuy Synthes (US), Braun Melsungen AG (Germany), NuVasive, Inc (US), Zimmer Biomet (US), Orthofix (US), and Globus Medical (US).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries.
Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
Table of Contents
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 RISING PREVALENCE OF CERVICAL SPONDYLOSIS IN CORPORATE PROFESSIONALS
4.2.2 GROWING CASES OF CERVICAL INJURIES IN AUTOMOBILE CRASHES
4.3 RESTRAINT
4.3.1 CONCERNS PERTAINING TO THE POST-SURGICAL PROCEDURES
4.4 OPPORTUNITY
4.4.1 EMERGENCE OF BIOMATERIAL CERVICAL FUSION IMPLANTS
5 MARKET FACTOR ANALYSIS
5.1 SUPPLY CHAIN ANALYSIS
5.1.1 R&D AND DESIGNING
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION & SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
6 GLOBAL CERVICAL FUSION MARKET, BY FUSION TYPE
6.1 OVERVIEW
6.2 ANTERIOR INTERBODY FUSION
6.3 ANTERIOR CERVICAL FUSION
6.4 POSTERIOR FUSION
7 GLOBAL CERVICAL FUSION MARKET, BY TYPE
7.1 OVERVIEW
7.2 METAL
7.3 POLYMER
7.4 OTHERS
8 GLOBAL CERVICAL FUSION MARKET, BY SURGERY
8.1 OVERVIEW
8.2 MINIMALLY INVASIVE SPINE SURGERY
8.3 OPEN SPINE SURGERY
9 GLOBAL CERVICAL FUSION MARKET, BY END USERS
9.1 OVERVIEW
9.2 ORTHOPAEDIC CLINICS
9.3 MULTISPECIALTY HOSPITALS
9.4 NEUROLOGY CLINICS
9.5 OTHERS
10 GLOBAL CERVICAL FUSION MARKET, BY REGION
10.1 OVERVIEW
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 UK
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 REST OF EUROPE
10.4 ASIA-PACIFIC
10.4.1 CHINA
10.4.2 INDIA
10.4.3 JAPAN
10.4.4 AUSTRALIA
10.4.5 SOUTH KOREA
10.4.6 REST OF ASIA-PACIFIC
10.5 REST OF THE WORLD
10.5.1 MIDDLE EAST
10.5.2 AFRICA
10.5.3 LATIN AMERICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPETITIVE BENCHMARKING
11.3 MAJOR GROWTH STRATEGY IN CERVICAL FUSION MARKET
11.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN CERVICAL FUSION MARKET
11.5 KEY DEVELOPMENT ANALYSIS
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.6.1 PRODUCT APPROVALS AND PRODUCT LAUNCHES
11.6.2 PARTNERSHIP/COLLABORATION
11.6.3 BUSINESS EXPANSIONS/AGREEMENTS
11.6.4 MERGERS & ACQUISITIONS
11.7 MAJOR PLAYERS SALES ANALYSIS
11.7.1 SALES & OPERATING INCOME
11.8 MAJOR PLAYERS R&D ANALYSIS
12 COMPANY PROFILE
12.1 MEDTRONIC INC.
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL OVERVIEW
12.1.3 PRODUCTS OFFERED
12.1.4 KEY DEVELOPMENTS
12.1.5 SWOT ANALYSIS
12.1.6 KEY STRATEGIES
12.2 ABBOTT LABORATORIES
12.2.1 COMPANY OVERVIEW
12.2.2 FINANCIAL OVERVIEW
12.2.3 PRODUCTS OFFERED
12.2.4 KEY DEVELOPMENTS
12.2.5 SWOT ANALYSIS
12.2.6 KEY STRATEGIES
12.3 STRYKER CORPORATION
12.3.1 COMPANY OVERVIEW
12.3.2 FINANCIAL OVERVIEW
12.3.3 PRODUCTS/SERVICES OFFERED
12.3.4 KEY DEVELOPMENTS
12.3.5 SWOT ANALYSIS
12.3.6 KEY STRATEGIES
12.4 DEPUY SYNTHES
12.4.1 COMPANY OVERVIEW
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 SWOT ANALYSIS
12.4.6 KEY STRATEGIES
12.5 B. BRAUN MELSUNGEN AG
12.5.1 COMPANY OVERVIEW
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS/SERVICES OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 SWOT ANALYSIS
12.5.6 KEY STRATEGIES
12.6 NUVASIVE, INC.
12.6.1 COMPANY OVERVIEW
12.6.2 FINANCIAL ANALYSIS
12.6.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.6.4 KEY DEVELOPMENTS
12.6.5 KEY STRATEGIES
12.7 ZIMMER BIOMET
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 SWOT ANALYSIS
12.7.6 KEY STRATEGIES
12.8 ORTHOFIX
12.8.1 COMPANY OVERVIEW
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS/SERVICES/SOLUTIONS 0FFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 KEY STRATEGIES
12.9 GLOBUS MEDICAL
12.9.1 COMPANY OVERVIEW
12.9.2 FINANCIAL OVERVIEW
12.9.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 KEY STRATEGIES
13 APPENDIX
13.1 REFERENCES
13.2 RELATED REPORTS
Companies Mentioned
Medtronic Inc (Ireland), Abbott Laboratories (US), Stryker Corporation (US), DePuy Synthes (US), Braun Melsungen AG (Germany), NuVasive, Inc (US), Zimmer Biomet (US), Orthofix (US), and Globus Medical (US).
Reviews
There are no reviews yet.